New software to detect overdose risk among drug users
November 29, 2012 in Medications
A new e-health tool that could help reduce the number of drug-related deaths in Europe will be launched in Brussels today.
The tool, developed by the Orion Project, financed by the European Commission and led by the University of St Andrews, is the first risk assessment tool of its kind. If rolled out successfully, researchers say the tool could help to significantly reduce cases of drug overdose.
Gerald Humphris, Professor of Health Psychology at St Andrews - one of the 4 European research groups involved in the research - said in advance of the launch, "Drug use is one of the major causes of health problems and mortality among young people in Europe and this is a concern for the medical community and regulators alike; this is why we were keen to develop a new tool to detect and raise awareness of the risks of drug overdose.
"The findings from our tests have shown that 45% of patients would consider changing their drug taking behaviour as a result of using the software."
The software is designed to help both patients and medical professionals identify key factors that lead to fatal overdoses.
Ms Antigoni Papadopoulou, Member of the European Parliament for Cyprus and convenor of the launch said. "Over the last decade, Europe has experienced about one overdose death every hour. Europe needs to support more tools and projects like this one that will help policy makers to understand how to prevent and reduce drug demand, particularly among the younger generations."
Representatives from EU Member States are meeting at the European Parliament to discuss a draft of the EU's drug strategy for 2013-2020. The strategy aims to contribute to a reduction in drug demand use and drug supply within the EU, as well as the health and social risks and harms caused by illicit drugs. The framework of this strategy will serve as basis for two consecutive 4 year EU Drugs Action plans.
More information: orion-euproject.com/
Provided by
University of St Andrews
-
Bristol-Pfizer anticlot drug gets key EU approval
Nov 20, 2012 |
not rated yet |
0
-
How men's lifestyles double their risk of an early death
Jun 17, 2011 |
not rated yet |
0
-
Methadone linked to 30 percent of painkiller overdoses
Jul 04, 2012 |
not rated yet |
0
-
Calls for policy changes as lives put at risk by bureaucracy
Feb 15, 2012 |
not rated yet |
0
-
EU committee rejects clone food plan
May 04, 2010 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
9 hours ago
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
-
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013
-
Alcohol and acetaminophen
May 13, 2013
-
Marie Curie's leukemia
May 13, 2013
- More from Physics Forums - Medical Sciences
More news stories
Acne pill benefits outweigh blood clot risk: EU agency
Europe's medicines watchdog said Friday the benefits of acne drug Diane-35, also widely used as a contraceptive, outweigh the risk of developing blood clots in the veins—when correctly prescribed.
Medications
May 17, 2013 |
not rated yet |
0
First influenza vaccine brought to clinical testing
Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their ...
Medications
May 17, 2013 |
not rated yet |
0
Aspirin not always best treatment for many individuals
(Medical Xpress)—An aspirin a day may not always keep heart disease away, say two University of Florida cardiologists. But a new algorithm they have developed outlines factors physicians should weigh as ...
Medications
May 16, 2013 |
3.5 / 5 (2) |
0
|
FDA: lower ambien's dose to prevent drowsy driving
(HealthDay)—The U.S. Food and Drug Administration has approved new, lower-dose labeling for the popular sleep drug Ambien (zolpidem) in an effort to cut down on daytime drowsiness that could be a hazard ...
Medications
May 15, 2013 |
not rated yet |
0
Simponi approved for ulcerative colitis
(HealthDay)—Simponi (golimumab) injection has been approved by the U.S. Food and Drug Administration to treat adults with moderate-to-severe ulcerative colitis.
Medications
May 15, 2013 |
not rated yet |
0
New research identifies risks, interventions for children's GI health
An increasing number of U.S. children are experiencing gastrointestinal issues that require interventions to resolve, according to research presented at Digestive Disease Week (DDW).
New colonoscope provides ground-breaking view of colon
A ground-breaking advance in colonoscopy technology signals the future of colorectal care, according to research presented today at Digestive Disease Week(DDW). Additional research focuses on optimizing the minimal withdrawal ...
AIDS science at 30: 'Cure' now part of lexicon
Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.
For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests
Chronic trauma can inflict lasting damage to brain regions associated with fear and anxiety. Previous imaging studies of people with post-traumatic stress disorder, or PTSD, have shown that these brain regions can over-or ...
Melon focus headband turns to Kickstarter for rollout plans
(Medical Xpress)—What if the quality of your work depends more on your focus on the piano keys or canvas or laptop than your musical or painting or computing skills? If target users can be convinced, they ...
Temporal processing in the olfactory system
The neural machinery underlying our olfactory sense continues to be an enigma for neuroscience. A recent review in Neuron seeks to expand traditional ideas about how neurons in the olfactory bulb might encode information about ...